HALOBETASOL PROPIONATE AND TAZAROTENE

HALOBETASOL PROPIONATE AND TAZAROTENE was reported 198 times

HALOBETASOL PROPIONATE AND TAZAROTENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BOWENOID PAPULOSIS 2 0.0870
1 APPLICATION SITE STREAKING 1 0.0769
2 INTRAUTERINE CONTRACEPTION 1 0.0588
3 THREAT OF REDUNDANCY 1 0.0370
4 APPLICATION SITE ATROPHY 1 0.0303
5 AMNIOTIC FLUID INDEX DECREASED 1 0.0278
6 ENDOVENOUS ABLATION 1 0.0152
7 FACIAL OPERATION 2 0.0124
8 CORNEAL ENDOTHELIITIS 1 0.0104
9 ACUTE CARDIAC EVENT 1 0.0058
10 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 1 0.0048
11 EOSINOPHILIC CELLULITIS 1 0.0047
12 COLD URTICARIA 1 0.0045
13 GENITAL ERYTHEMA 2 0.0040
14 KERATOACANTHOMA 2 0.0029
15 APPLICATION SITE LACERATION 1 0.0024
16 VULVAL CANCER 1 0.0017
17 PERIORAL DERMATITIS 1 0.0016
18 CELLULITIS STAPHYLOCOCCAL 1 0.0015
19 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
20 CYST RUPTURE 1 0.0015
21 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
22 SKIN INDURATION 3 0.0014
23 FOETAL HYPOKINESIA 1 0.0014
24 ALLERGIC COUGH 1 0.0013
25 BLISTER INFECTED 1 0.0013
26 PUSTULE 3 0.0013
27 GOUTY ARTHRITIS 1 0.0013
28 SKIN EROSION 4 0.0012
29 DENTAL IMPLANTATION 2 0.0012
30 COVID-19 IMMUNISATION 1 0.0012
31 ADENOMA BENIGN 1 0.0012
32 SKIN HYPOPIGMENTATION 2 0.0011
33 UTERINE PROLAPSE 1 0.0009
34 NAIL GROWTH ABNORMAL 1 0.0009
35 LICHENOID KERATOSIS 2 0.0009
36 CHEMICAL BURN 1 0.0009
37 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
38 DYSPLASIA 1 0.0008
39 EXFOLIATIVE RASH 2 0.0008
40 SKIN DEPIGMENTATION 1 0.0007
41 APPLICATION SITE INFLAMMATION 1 0.0007
42 SKIN ATROPHY 4 0.0007
43 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
44 APPLICATION SITE IRRITATION 8 0.0006
45 ACUTE SINUSITIS 1 0.0006
46 SEBORRHOEA 2 0.0005
47 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
48 APPLICATION SITE EXFOLIATION 2 0.0005
49 APPLICATION SITE SCAB 1 0.0005
50 APPLICATION SITE PAIN 10 0.0005
51 DANDRUFF 1 0.0005
52 BRAIN OPERATION 1 0.0004
53 IMPLANT SITE INFECTION 1 0.0004
54 SQUAMOUS CELL CARCINOMA 4 0.0004
55 SKIN ABRASION 2 0.0004
56 LIMB OPERATION 2 0.0004
57 CHEMICAL BURN OF SKIN 1 0.0004
58 ANGLE CLOSURE GLAUCOMA 1 0.0004
59 PSORIASIS 50 0.0004
60 BREAST SWELLING 1 0.0004
61 GASTRIC PERFORATION 1 0.0004
62 APPLICATION SITE HAEMORRHAGE 1 0.0004
63 DIABETIC FOOT 1 0.0003
64 MENISCUS INJURY 2 0.0003
65 FAMILY STRESS 1 0.0003
66 POLYMYALGIA RHEUMATICA 1 0.0003
67 APPLICATION SITE ERYTHEMA 8 0.0003
68 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
69 HAIR GROWTH ABNORMAL 2 0.0003
70 MAJOR DEPRESSION 2 0.0003
71 NEURODERMATITIS 1 0.0003
72 APPLICATION SITE DISCOLOURATION 1 0.0002
73 SHOULDER OPERATION 1 0.0002
74 HORDEOLUM 1 0.0002
75 MELANOCYTIC NAEVUS 1 0.0002
76 PARONYCHIA 1 0.0002
77 INJECTION SITE PAPULE 1 0.0002
78 APPLICATION SITE RASH 3 0.0002
79 PRODUCT DISTRIBUTION ISSUE 2 0.0002
80 ROSACEA 1 0.0002
81 SKIN TIGHTNESS 1 0.0002
82 SUBCUTANEOUS ABSCESS 1 0.0002
83 APPLICATION SITE BURN 1 0.0002
84 DRUG TOLERANCE 1 0.0002
85 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
86 ANAL FISSURE 1 0.0002
87 NORMAL NEWBORN 1 0.0002
88 HYPERKERATOSIS 1 0.0002
89 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
90 APPLICATION SITE PRURITUS 4 0.0002
91 DERMATITIS CONTACT 2 0.0002
92 SYMPTOM RECURRENCE 1 0.0002
93 OSTEOMYELITIS 3 0.0002
94 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
95 PIGMENTATION DISORDER 1 0.0002
96 BLOOD TESTOSTERONE DECREASED 1 0.0001
97 LYMPHOEDEMA 1 0.0001
98 KNEE ARTHROPLASTY 3 0.0001
99 THERMAL BURN 1 0.0001
100 SKIN BURNING SENSATION 10 0.0001
101 SENSITIVE SKIN 1 0.0001
102 THERAPY NON-RESPONDER 6 0.0001
103 SKIN IRRITATION 6 0.0001
104 BOWEL MOVEMENT IRREGULARITY 1 0.0001
105 ANKLE FRACTURE 2 0.0001
106 BASAL CELL CARCINOMA 2 0.0001
107 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
108 PSORIATIC ARTHROPATHY 5 0.0001
109 SENSATION OF FOREIGN BODY 1 0.0001
110 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
111 DERMATITIS ATOPIC 6 0.0001
112 PURPURA 1 0.0001
113 FACIAL PAIN 1 0.0001
114 PAIN OF SKIN 3 0.0001
115 SKIN EXFOLIATION 9 0.0001
116 KIDNEY INFECTION 2 0.0001
117 EYE DISCHARGE 1 0.0001
118 SCRATCH 1 0.0001
119 BODY HEIGHT DECREASED 1 0.0001
120 PRODUCT PRESCRIBING ISSUE 2 0.0001
121 BLOOD GLUCOSE FLUCTUATION 1 0.0001
122 EYE INFECTION 1 0.0001
123 REBOUND EFFECT 1 0.0001
124 SKIN DISCOLOURATION 4 0.0001
125 BLOOD IRON DECREASED 1 0.0001
126 LOCALISED INFECTION 2 0.0001
127 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
128 CYST 1 0.0001
129 TOOTH EXTRACTION 1 0.0001
130 DERMATITIS ALLERGIC 1 0.0001
131 TOOTH INFECTION 1 0.0001
132 ABORTION SPONTANEOUS 3 0.0001
133 BURNING SENSATION 5 0.0001
134 ANOSMIA 1 0.0001
135 DEVICE DISLOCATION 3 0.0001
136 SKIN HAEMORRHAGE 1 0.0001
137 BONE LOSS 1 0.0001
138 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
139 MUSCULOSKELETAL CHEST PAIN 1 0.0001
140 PRODUCT USE COMPLAINT 1 0.0001
141 ULCER 1 0.0001
142 RASH ERYTHEMATOUS 3 0.0001
143 BACK DISORDER 1 0.0001
144 TREATMENT FAILURE 5 0.0001
145 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
146 SKIN DISORDER 2 0.0001
147 CANDIDA INFECTION 1 0.0001
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
149 ECZEMA 3 0.0001
150 COLD SWEAT 1 0.0001
151 SLEEP DISORDER 4 0.0001
152 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
153 GOUT 1 0.0001
154 GASTROENTERITIS VIRAL 1 0.0001
155 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
156 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
157 FEELING JITTERY 1 0.0001
158 INCREASED APPETITE 1 0.0001
159 LOWER LIMB FRACTURE 1 0.0001
160 HAEMORRHOIDS 1 0.0001
161 SKIN FISSURES 1 0.0001
162 PRODUCT DOSE OMISSION ISSUE 15 0.0001
163 UPPER LIMB FRACTURE 1 0.0001
164 THERAPEUTIC RESPONSE DECREASED 3 0.0000
165 JOINT INJURY 1 0.0000
166 IRRITABLE BOWEL SYNDROME 1 0.0000
167 LIVER FUNCTION TEST INCREASED 1 0.0000
168 POOR QUALITY SLEEP 1 0.0000
169 SKIN CANCER 1 0.0000
170 SWELLING FACE 3 0.0000
171 DRY SKIN 6 0.0000
172 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
173 SNEEZING 1 0.0000
174 THROAT IRRITATION 2 0.0000
175 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
176 PRODUCT AVAILABILITY ISSUE 1 0.0000
177 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
178 DISEASE RECURRENCE 2 0.0000
179 PRURITUS 16 0.0000
180 AGEUSIA 1 0.0000
181 COVID-19 7 0.0000
182 CELLULITIS 2 0.0000
183 PERIPHERAL SWELLING 6 0.0000
184 ERECTILE DYSFUNCTION 1 0.0000
185 ERYTHEMA 8 0.0000
186 ANAPHYLACTIC SHOCK 1 0.0000
187 SKIN ULCER 1 0.0000
188 BREAST CANCER FEMALE 1 0.0000
189 RASH PRURITIC 2 0.0000
190 SKIN LESION 1 0.0000
191 PROCEDURAL PAIN 1 0.0000
192 WOUND 1 0.0000
193 PAIN IN JAW 1 0.0000
194 INTENTIONAL DOSE OMISSION 1 0.0000
195 NEEDLE ISSUE 1 0.0000
196 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
197 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
198 JOINT SWELLING 4 0.0000
199 EMOTIONAL DISORDER 1 0.0000
200 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
201 SWELLING 3 0.0000
202 MOVEMENT DISORDER 1 0.0000
203 STAPHYLOCOCCAL INFECTION 1 0.0000
204 ILLNESS 3 0.0000
205 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
206 INJECTION SITE REACTION 2 0.0000
207 RASH MACULAR 1 0.0000
208 THERAPY INTERRUPTED 2 0.0000
209 CRYING 1 0.0000
210 INJECTION SITE MASS 1 0.0000
211 EYE SWELLING 1 0.0000
212 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
213 INJECTION SITE HAEMORRHAGE 2 0.0000
214 ROAD TRAFFIC ACCIDENT 1 0.0000
215 DEVICE LEAKAGE 1 0.0000
216 RASH 10 0.0000
217 HEADACHE 14 0.0000
218 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
219 TINNITUS 1 0.0000
220 MIGRAINE 2 0.0000
221 PRODUCTIVE COUGH 1 0.0000
222 AGGRESSION 1 0.0000
223 SINUSITIS 2 0.0000
224 THERAPY CESSATION 1 0.0000
225 ABDOMINAL PAIN UPPER 4 0.0000
226 NERVOUSNESS 1 0.0000
227 DEPRESSED MOOD 1 0.0000
228 DISTURBANCE IN ATTENTION 1 0.0000
229 ARTHROPATHY 1 0.0000
230 INFLUENZA 2 0.0000
231 SEPSIS 2 0.0000
232 NECK PAIN 1 0.0000
233 BLISTER 1 0.0000
234 MUSCULAR WEAKNESS 2 0.0000
235 HERPES ZOSTER 1 0.0000
236 EYE IRRITATION 1 0.0000
237 DYSPHONIA 1 0.0000
238 CHILLS 2 0.0000
239 SURGERY 1 0.0000
240 DIARRHOEA 11 0.0000
241 NASAL CONGESTION 1 0.0000
242 CATARACT 1 0.0000
243 IRRITABILITY 1 0.0000
244 ILL-DEFINED DISORDER 1 0.0000
245 FEELING HOT 1 0.0000
246 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
247 GAIT DISTURBANCE 3 0.0000
248 RHINORRHOEA 1 0.0000
249 PNEUMONIA 5 0.0000
250 PRODUCT DOSE OMISSION 1 0.0000
251 NAUSEA 12 0.0000
252 NEOPLASM MALIGNANT 1 0.0000
253 DRUG INEFFECTIVE 19 0.0000
254 AGITATION 1 0.0000
255 UNEVALUABLE EVENT 1 0.0000
256 BLOOD PRESSURE INCREASED 2 0.0000
257 PAIN 8 0.0000
258 DECREASED APPETITE 3 0.0000
259 VOMITING 6 0.0000
260 INJECTION SITE BRUISING 1 0.0000
261 FEELING ABNORMAL 3 0.0000
262 INFLUENZA LIKE ILLNESS 1 0.0000
263 ARTHRALGIA 5 0.0000
264 URTICARIA 2 0.0000
265 ABDOMINAL DISCOMFORT 2 0.0000
266 MYALGIA 2 0.0000
267 GASTROINTESTINAL DISORDER 1 0.0000
268 OROPHARYNGEAL PAIN 1 0.0000
269 HYPERSENSITIVITY 2 0.0000
270 BREAST CANCER 1 0.0000
271 DRUG INTOLERANCE 1 0.0000
272 OFF LABEL USE 9 0.0000
273 ATRIAL FIBRILLATION 1 0.0000
274 DYSPEPSIA 1 0.0000
275 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
276 FATIGUE 7 0.0000
277 RHEUMATOID ARTHRITIS 1 0.0000
278 DEPRESSION 2 0.0000
279 ABDOMINAL PAIN 2 0.0000
280 PALPITATIONS 1 0.0000
281 DIZZINESS 4 0.0000
282 LOSS OF CONSCIOUSNESS 1 0.0000
283 HYPERHIDROSIS 1 0.0000
284 DEHYDRATION 1 0.0000
285 PRODUCT QUALITY ISSUE 1 0.0000
286 VISION BLURRED 1 0.0000
287 COUGH 2 0.0000
288 INFECTION 1 0.0000
289 CONDITION AGGRAVATED 2 0.0000
290 INJECTION SITE PAIN 2 0.0000
291 HOSPITALISATION 1 0.0000
292 URINARY TRACT INFECTION 1 0.0000
293 PYREXIA 2 0.0000
294 MYOCARDIAL INFARCTION 1 0.0000
295 MUSCLE SPASMS 1 0.0000
296 NASOPHARYNGITIS 1 0.0000
297 BLOOD GLUCOSE INCREASED 1 0.0000
298 ALOPECIA 1 0.0000
299 SOMNOLENCE 1 0.0000
300 HYPERTENSION 1 0.0000
301 WEIGHT INCREASED 1 0.0000
302 INCORRECT DOSE ADMINISTERED 1 0.0000
303 BACK PAIN 1 0.0000
304 WEIGHT DECREASED 1 0.0000
305 ANXIETY 1 0.0000
306 PAIN IN EXTREMITY 1 0.0000
307 FALL 1 0.0000
308 ASTHENIA 1 0.0000
309 DYSPNOEA 1 0.0000